Skip to main content
Log in

Lipophilic Imidazolylpyridines with Antimicrobial Activity

  • SEARCH FOR NEW DRUGS
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The reaction of nicotinic and isonicotinic propargylamides with lipophilic aliphatic amines yielded a series of 3- or 4-(5-methyl-1H-imidazol-2-yl)pyridines containing a lipophilic substituent in the imidazole ring 1-position. The new compounds were characterized by physicochemical methods. The antituberculosis and antimicrobial activities against ESKAPE pathogens were studied. 3-[1-(1-n-Octadecyl)-5-methyl-1Himidazol-2-yl]pyridine (IIId) had antituberculosis activity (MIC 6.2 μg/mL) while 3-[1-(1-adamantylmethyl)-5-methyl-1H-imidazol-2-yl]pyridine (IIIa) exhibited activity against S. aureus (MIC 16 μg/mL).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

References

  1. Y. Q. Hu, S. Zhang, F. Zhao, et al., Eur. J. Med. Chem., 133, 255 – 267 (2017).

    Article  CAS  PubMed  Google Scholar 

  2. S. S. Swain, S. K. Paidesetty, R. N. Padhy, et al., Chem. Biol. Drug Des., 96, No. 2, 714 – 730 (2020).

    Article  CAS  PubMed  Google Scholar 

  3. V. Pflegr, J. Maixnerova, J. Stolarikova, et al., Pharmaceuticals (Basel), 14, No. 12 (2021).

  4. S. Perveen, D. Kumari, K. Singh, et al., Eur. J. Med. Chem., 229, 114066 (2022).

    Article  CAS  PubMed  Google Scholar 

  5. G. Navarrete-Vazquez, G. M. Molina-Salinas, Z. V. Duarte-Fajardo, et al., Bioorg. Med. Chem., 15(16), 5502 – 5508 (2007).

    Article  CAS  PubMed  Google Scholar 

  6. D. Mata-Espinosa, G. M. Molina-Salinas, J. Barrios-Payan, et al., Pulm. Pharmacol. Ther., 32, 7 – 14 (2015).

    Article  CAS  PubMed  Google Scholar 

  7. R. Vosatka, M. Kratky, M. Svarcova, et al., Eur. J. Med. Chem., 151, 824 – 835 (2018).

    Article  CAS  PubMed  Google Scholar 

  8. D. Atukuri, R. Gunjal, N. Holagundi, et al., Drug Dev. Res., 82(6), 767 – 783 (2021).

    Article  CAS  PubMed  Google Scholar 

  9. E. R. Erwin, A. P. Addison, S. F. John, et al., Tuberculosis (Edinburgh, Scotland), 116, Suppl., S66-S70 (2019).

  10. Z. S. Bhat, M. A. Rather, M. Maqbool, et al., Biomed. Pharmacother., 95, 1520 – 1534 (2017).

    Article  CAS  PubMed  Google Scholar 

  11. L. Wanka, K. Iqbal, and P. R. Schreiner, Chem. Rev., 113(5), 3516 – 3604 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. S. Agarwal (ed.), Imidazole-Based Drug Discovery, Elsevier (2021).

  13. M. Krasavin, A. Lukin, T. Vedekhina, et al., Eur. J. Med. Chem., 157, 1115 – 1126 (2018).

    Article  CAS  PubMed  Google Scholar 

  14. J. C. Palomino, A. Martin, M. Camacho, et al., Antimicrob. Agents Chemother., 46(8), 2720 – 2722 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. S. Vedekhina.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 6, pp. 18 – 23, June, 2023.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vedekhina, T.S., Dogonadze, M.Z., Vinogradova, T.I. et al. Lipophilic Imidazolylpyridines with Antimicrobial Activity. Pharm Chem J 57, 816–821 (2023). https://doi.org/10.1007/s11094-023-02954-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-023-02954-6

Keywords

Navigation